SE8306475L - Cefalosporinantibiotika - Google Patents

Cefalosporinantibiotika

Info

Publication number
SE8306475L
SE8306475L SE8306475A SE8306475A SE8306475L SE 8306475 L SE8306475 L SE 8306475L SE 8306475 A SE8306475 A SE 8306475A SE 8306475 A SE8306475 A SE 8306475A SE 8306475 L SE8306475 L SE 8306475L
Authority
SE
Sweden
Prior art keywords
gram
cephalosporin antibiotics
toxic
dioxotriazine
tetrazole
Prior art date
Application number
SE8306475A
Other languages
English (en)
Other versions
SE8306475D0 (sv
Inventor
B E Looker
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of SE8306475D0 publication Critical patent/SE8306475D0/sv
Publication of SE8306475L publication Critical patent/SE8306475L/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8306475A 1982-11-24 1983-11-23 Cefalosporinantibiotika SE8306475L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8233521 1982-11-24

Publications (2)

Publication Number Publication Date
SE8306475D0 SE8306475D0 (sv) 1983-11-23
SE8306475L true SE8306475L (sv) 1984-05-25

Family

ID=10534479

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8306475A SE8306475L (sv) 1982-11-24 1983-11-23 Cefalosporinantibiotika

Country Status (18)

Country Link
JP (1) JPS59106492A (sv)
KR (1) KR840006811A (sv)
AU (1) AU2161783A (sv)
BE (1) BE898293A (sv)
DE (1) DE3342317A1 (sv)
DK (1) DK535083A (sv)
FI (1) FI834297A (sv)
FR (1) FR2536402A1 (sv)
GB (1) GB2132193B (sv)
GR (1) GR79078B (sv)
IL (1) IL70310A0 (sv)
IT (1) IT1175800B (sv)
LU (1) LU85101A1 (sv)
NL (1) NL8304024A (sv)
NO (1) NO834304L (sv)
PT (1) PT77711B (sv)
SE (1) SE8306475L (sv)
ZA (1) ZA838733B (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0148004A3 (en) * 1983-12-30 1986-04-23 Glaxo Group Limited Cephalosporin antibiotics
US5202315A (en) * 1989-05-11 1993-04-13 Lucky, Ltd. Cephalosporin compounds
DK0449515T3 (da) * 1990-03-24 1995-10-16 Lucky Ltd Hidtil ukendte cephalosporin-mellemprodukter og fremgangsmåde til fremstilling af mellemprodukterne og slutprodukter deraf

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2714880A1 (de) * 1977-04-02 1978-10-26 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
GB2027691B (en) * 1978-05-26 1983-03-02 Glaxo Group Ltd Cephalosporin antibiotics

Also Published As

Publication number Publication date
JPS59106492A (ja) 1984-06-20
DK535083D0 (da) 1983-11-23
IT1175800B (it) 1987-07-15
NO834304L (no) 1984-05-25
ZA838733B (en) 1985-01-30
GB2132193A (en) 1984-07-04
LU85101A1 (fr) 1984-06-13
GB2132193B (en) 1985-12-18
AU2161783A (en) 1984-05-31
PT77711B (pt) 1986-03-27
FR2536402A1 (fr) 1984-05-25
FI834297A (fi) 1984-05-25
IT8349380A0 (it) 1983-11-23
DK535083A (da) 1984-05-25
GB8331292D0 (en) 1983-12-29
KR840006811A (ko) 1984-12-03
FI834297A0 (fi) 1983-11-23
GR79078B (sv) 1984-10-02
SE8306475D0 (sv) 1983-11-23
DE3342317A1 (de) 1984-05-24
IL70310A0 (en) 1984-02-29
BE898293A (fr) 1984-05-23
NL8304024A (nl) 1984-06-18
PT77711A (en) 1983-12-01

Similar Documents

Publication Publication Date Title
ES467601A1 (es) Procedimiento para la preparacion de derivados de cefem.
ES8703884A1 (es) Un procedimiento para preparar antibioticos de cefalosporina.
SE7908896L (sv) Cefalosporinforeningar
SE8306475D0 (sv) Cefalosporinantibiotika
SE7909501L (sv) Cefalosporin-antibiotika
ATE11221T1 (de) Antibaktierielle zusammensetzungen, die eine beta-lactam-verbindung und eine 3-substituiertes propenoat enthalten.
ATE32724T1 (de) Cephalosporinverbindungen, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
SE7908895L (sv) Cefalosporinforeningar
SE8303727D0 (sv) Cefalosporinantibiotika
SE7709646L (sv) Antibakteriella medel
ES8504818A1 (es) Procedimiento para la obtencion de compuestos del acido 7-acilamido-3-cefem-4-carboxilico.
FR2426692A1 (fr) Antibiotiques du type cephalosporine et leur procede de preparation
IE44393L (en) Cephalosporin compounds.
SE8303728D0 (sv) Cefalosporinantibiotika
ES8307822A1 (es) Procedimiento para la obtencion de acido 7b-acilamido-3-cefem-4-carboxilico.
SE8105628L (sv) Cefalosporinderivat

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8306475-8

Effective date: 19851018